Featured Videos | view more
A Penn pharmacist discusses Penn Medicine’s Multiple Sclerosis and Related Disorders Center.
Penn Medicine expert, Dr. Amit Bar-Or discusses the latest multiple sclerosis research at Penn Medicine’s Center for Neuroinflammation and Neurotherapeutics at the Perelman School of Medicine.
Providers discuss Penn Medicine’s Multiple Sclerosis and Related Disorders Center.
Featured Articles & Documents |view more
Retrospective study suggests MitraClip benefits outweigh slight increase in mitral valve gradient
For the first time, researchers led by SU2C “Dream Team” show how CD40 agonist drives an immune response to hard-to-penetrate tumors
Thursday, June 17, 2021 11:00 AM
The COVID-19 death rate for Black patients would be 10 percent lower if they had access to the same hospitals as white patients, a new study shows.
Tuesday, June 15, 2021 12:51 PM
The 2021 Pew Scholars in the Biomedical Sciences were chosen from 198 applicants nominated by leading academic institutions and researchers across the United States. These scientists will receive funding over the next four years as they ...
Friday, June 11, 2021 7:45 AM
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, according to a new JAMA Oncology study of nearly 30,000 patients led by researchers in the Basser Center for BRCA at the Abramson Cancer Center.
Friday, May 28, 2021 8:00 PM
Penn trauma surgeons have conducted the largest multi-center retrospective study to date to evaluate the outcome and management of patients who have undergone zone 3 REBOA deployment for the management of severe pelvic fractures.
Wednesday, May 12, 2021 8:00 PM
Three Penn clinicians and academics are co-founding members of DearPandemic.org, a website with a trusted network of scientists answering questions from the general public to tackle misinformation around COVID-19.
Monday, May 3, 2021 8:00 PM
Data from a clinical trial co-led by Penn Medicine’s Katharine J. Bar, MD, suggests that Regeneron’s monoclonal antibody shot, “REGEN-COV”, can reduce the risk of asymptomatic to symptomatic COVID-19 infection progression by almost one third.
VIRTUAL Thursday, July 15, 2021, 5 – 8:30pm Type of Event: CME Course, Conference Sponsor: Abramson Cancer Center Learning Objectives: At the completion of this course, participants should be able to:, ...
Thursday, October 14, 2021 Location: Virtual Type of Event: CME Course Sponsor: Abramson Cancer Center Learning Objectives: At the completion of this course, participants should be able to: Describe clinical pathways ...